logologo
QuantliQuantli

Zymeworks Inc

ZYME

NASDAQ

Biotechnology

$25.12

USD

-0.64 (-2.48%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $1.79B

Volume 332.5K

Price Target

$37.00$46.00

USD

The 2 analysts offering 1-year price forecasts have a max estimate of $46.00 and a min estimate of $37.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$41.50

-$5.1 vs prior

Implied Upside

+65.2%

-20.3% vs prior

Analyst Covering

2

-3 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

29%

Many ratings are older - consensus may be less current

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

2 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

2 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Eva Fortea Verdejo

Wells Fargo

Buy

Maintained

1 month ago

Plus
Plus
Plus

Robert Burns

HC Wainwright & Co.

Buy

Reiterated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

AUPH

Aurinia Pharmaceuticals Inc

$15.47

+1.9%

XENE

Xenon Pharmaceuticals Inc

$62.35

-2.9%

ABUS

Arbutus Biopharma Corp

$4.67

+2.0%

ACOG

Alpha Cognition Inc

$8.84

+2.4%

PMN

ProMIS Neurosciences Inc

$14.86

+0.5%